Resolved

POTASSIUM PHOSPHATES INJECTION, USP

FRESENIUS KABI CANADA LTD

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of POTASSIUM PHOSPHATES INJECTION, USP in Canada?

Not currently. The most recent shortage report for POTASSIUM PHOSPHATES INJECTION, USP 224MG 236MG is marked resolved (last updated October 27, 2026).

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength224MG 236MG

Report last updated2026-10-27

Checked by MedShort2026-11-13

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02139545

Strength

224MG 236MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

POTASSIUM PHOSPHATE MONOBASIC POTASSIUM PHOSPHATE DIBASIC

Tier

Unrated

Last Updated

2026-10-27

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from FRESENIUS KABI CANADA LTD

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION

900MG · DIN 02395150

2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION

20MG · DIN 02538644

5% DEXTROSE INJECTION

50MG · DIN 02403536

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02236926

ADDNUTRIV

DIN 02497697

ADENOSINE INJECTION

3MG · DIN 02267659